ABSTRACT A human metallothionein (MT) gene was inserted into a bovine papillomavirus (BPV) vector. The chimeric vector (pMTII-BPV) transforms rodent fibroblasts to a cadmium-resistant phenotype. The resistance is due to the high level of expression of human MT-Il in those cells. The vector is maintained in the cells as a free replicating plasmid, present at about 10-15 copies per cell. Transcription of the episomal human MT-IIA gene is initiated from its authentic start sites and is regulated by the level of cadmium in the growth medium. The presence of the human MT-IIA gene allows the BPV replicon to function even though it is ligated to an intact copy of pBR322. Due to the presence of plasmid origins of replication and dominantly acting selective markers functional in both Escherichia coli and mammalian cells, pMTI-BPV can be used as a shuttle vector.
Metallothioneins (MTs) are low molecular weight heavy metalbinding proteins. They are responsible for protection of living cells against the toxic effects of heavy metals (1) . In cultured human cells, MTs are induced by exposure to heavy metal ions (2) or glucocorticoids (3) . The increase in protein levels is mediated through increased synthesis of MT mRNA (4) (5) (6) , which is due to increased transcription rates after treatment with either heavy metals or glucocorticoids (7, 8) . To gain a better understanding of the molecular mechanisms controlling the expression of human MT genes, we have isolated a cDNA clone of human MT-II mRNA (9) and used it as a hybridization probe to isolate at least 12 different human MT genes from a genomic DNA library (10) . We chose to study in detail the expression of the MT-IIA gene (11) because it codes for the most abundantly expressed human MT subtype (12) .
After introduction of the human MT-IA gene into Rat 2 cells by cotransfer, we noticed a wide variation in its level of expression and the type of regulation (unpublished data). The variation in levels of expression is probably due to random integration at variable distances from endogenous cellular "enhancer" sequences (13) . To study the expression of the human MT-IIA gene without interference from neighboring regulatory sequences, we have inserted the gene into a bovine papillomavirus (BPV) vector (14) . BPV genomic DNA and various vectors derived from it have the unique property of being able to replicate autonomously as episomes in mammalian cells (15) . After introduction of MT-BPV vectors into rodent fibroblasts, the human MT-hIA gene is expressed and regulated in identical fashion in different transfected cell lines. Due to the high level of expression after heavy metal induction, the transfected cells containing the vector can be selected directly for cadmium resistance (Cdr). In the past, it has been observed that physical linkage of pBR322 sequences to the subgenomic transforming fragment of BPV leads to a severe (to <1%) decrease in transformation efficiency by the virus (16) . Interestingly, the presence of the human MT-IA gene in the vector allows replication, in mammalian cells, of BPV linked to pBR322.
MATERIALS AND METHODS
Restriction enzymes were used according to the manufacturer's recommendations (Bethesda Research Laboratories). A 3.0-kilobase (kb) HindIII fragment containing the human MT-IIA gene, including 0.8 kb of the 5' flanking region (11), was isolated by electrophoresis on a 1% agarose gel and electroelution.
pBPV69TDNA [ (6) . Nuclei were pelleted and used for isolation of either total cellular (20) or episomal DNA (21) . Total cellular RNA was isolated from the cytosols as described (6) . DNA was analyzed by electrophoresis on 1% agarose gels and blot hybridization (22) . RNA was denatured by glyoxalation and analyzed on 1.5% agarose gels according to Thomas (23) . Hybridization probes were prepared by nick-translation (24) . Hybridization and washing procedures were as described by Wahl et aL (25) . Mung bean nuclease mapping was performed as described (11) .
RESULTS
Transformation and Selection of Cdr Cells. For our initial experiments we chose the plasmid vector pMTII-BPV(-) (Fig.  1) . In those experiments, vector DNA was digested with Sal I prior to transfection to achieve physical separation of the fragment containing both MTII and BPV sequences from pBR322 sequences in order to achieve efficient transformation (16 (9) . Numbers at the right indicate the size (in kb) of restriction fragments of bacteriophage PM2 used as markers.
vector (Fig. 3) . Moreover, expression of the human MT-II gene in its new environment was regulated by the concentration of Cd2" in the growth medium (lanes A-D) . Two (Fig. 5 A and D) . The presence or absence of pBR322 sequences in the vector had no effect on its copy number in the resistant cells.
We Fig. 1 (Fig. 5D) . In undigested cellular DNA, MTII-BPV was present as a high molecular weight, probably catenated, form (Fig. 5 A and D) . Mechanical shearing and partial digestion with EcoRI released forms I, II, and III DNA from those complexes (Fig. 5B) . Migration of the vector as a high molecular weight form was not due to trapping within the genomic DNA because the plasmid mixed with high molecular weight carrier DNA did migrate properly (Fig. 5 A and D) . Second, we subjected several Cdr lines to Hirt extraction (21) , to separate free replicating circular DNA from high molecular weight chromosomal DNA. pMTII-BPV DNA was present mostly in the supernatant, as expected of episomal DNA (Fig. 5C ).
In addition to C127 and NIH 3T3 cells, Rat 2 cells also were transformed to a Cd' phenotype by transfection with pMTII-BPV with the same efficiency as mouse C127 cells. After several of the Cdr colonies were propagated into mass cultures, they no longer exhibited contact inhibition of growth, and multiple foci appeared at high cell densities. Therefore, we conclude that Rat 2 cells can be oncogenically transformed by BPV. Cellular DNA from several of the Rat 2 Cdr lines was found to contain approximately 10-15 copies of free replicating pMTII-BPV (Fig.   5D ).
Rescue of Vector DNA from Mammalian Cells. Because pMTII-BPV vectors replicated in mammalian cells while still linked to pBR322 DNA, and no deletions or rearrangements were found to occur within those sequences (Fig. 5D) , it should be possible to rescue the vector DNA from mammalian cells by transformation of E. coli. Between 355 and 685 ampicillin-resistant colonies were detected after transformation of E. coli (RRI) with either Hirt (21) or alkaline extracts (31) of about 107 mammalian cells. Some of the bacterial colonies were analyzed by rapid plasmid DNA preparation (17) and were found to contain the original pMTII-BPV DNA (data not shown). In other experiments, in which the human MT-II gene was introduced into either Ltk-or Rat 2 cells by cotransfer with the herpes simplex thymidine kinase gene, the level of expression and its regulation varied considerably from one clone to another (unpublished data). This probably was due to random integration into various sites in the host genome. All of the Cdr clones generated by transformation with the pMTII-BPV vectors that we have analyzed exhibited similar levels of human MT-II mRNA expression, most likely as a result of the episomal state of such vectors and the presence, on the BPV69T fragment, of an enhancer sequence (32) . Therefore, such episomal vectors would facilitate studies correlating chromatin structure and gene expression of isolated and in vitro mutagenized genes without integration site interference.
DISCUSSION
We have been unable to detect any response to glucocorti- Besides being an easily selectable, dominantly acting, genetic marker, the human MT-IIA gene has another highly desirable property: it can counteract the deleterious effect of pBR322 sequences on BPV replication (16) . Several other genes have such an effect (28, 30, 35) . This property of the MT-IIA gene can be extended, and other genes can be inserted into the pMTII-BPV vectors and propagated extrachromosomally without removal of pBR322 sequences (unpublished data).
Because the pMTII-BPV vectors contain plasmid origins of replication and selectable markers for both E. coli and mammalian cells, they can serve as shuttle vectors. Such vectors can be used for gene cloning and for isolation of mutants of already cloned genes present on such vectors.
